Sustaguard Artro - new preparation of glucosamine sulfate for the treatment of osteoarthrosis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Effective therapy of osteoarthrosis (OA) is a difficult task due to the chronic and steadily progressing course, sometimes without any apparent predisposing factors. However, we should strive to do everything possible to prevent the serious structural changes in joint tissues. Glucosamine sulfate has reliable symptom-modifying properties, helping to reduce the intensity of pain and stiffness, and improve the functional activity of the target joints. This drug has the potential pathogenetic structure-modifying (basic) action aimed at reducing the rate of cartilage degeneration. Pharmaceutical activity of glucosamine sulphate allows its successful use in the treatment of OA, primarily the knee OA.

Full Text

Restricted Access

About the authors

V. V Badokin

FSBE IFPE “Russian Medical Academy of Postgraduate Education" of RMH

MD, Prof., Head ofthe Department of Rheumatology

References

  1. Source Frost & Sullivan Market Insight - 2013.
  2. Бадокин В.В. Мультифакториальность механизмов действия НПВП при остеоартрозе. Современная ревматология 2009;4:81-9.
  3. Bruyere O., Cooper C., Pelletier J.P., Branco J., Luisa Brandi M., Guillemin F., Hochberg M.C., Kanis J.A., Kvien T.K., Martel-PelletierJ., Rizzoli R., Silverman S., Reginster J.Y. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin. Arthritis Rheum. 2014;44:253-63.
  4. Glucosamine Sulfate. Product monograph. 2000. Rottapharm Group.
  5. Кригштейн О.С., Голубев Г.Ш. Оценка доказательств эффективности средств, претендующих называться «структурно-модифицирующими препаратами», 2004-2007 гг. Клинич. фармакол. и фармакоэкономика 2008; 1:55-88.
  6. Jordan K.M., Arden N.K., Doherty M., et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum. Dis. 2003;62:1145-55.
  7. Reginster J.Y., Cooper C., Hochberg M., Pelletier J.P., Rizzoli R., Kanis J., Abadie E., Maheu E., Brandi M.L., Devogelaer J.P, Branco J., Herrero-Beaumont G., D'Hooghe P., Bruyère O. Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Curr. Med. Res. Opin. 2015;31:1041-45.
  8. Cutolo M., Berenbaum F., Hochberg M., Punzi L., Reginster J.Y. Commentary on recent therapeutic guidelines for osteoarthritis. Semin. Arthritis Rheum. 2014;44:611-17.
  9. Кухарц Е.Дж., Коваленко В., Сзанто С. и др. Обзор применения глюкозамина при остеоартрозе коленного сустава: почему патентован ный кристаллический глюкозамина сульфат должен быть дифференцирован от других глюкозаминов с целью максимизации клинического результата. Украинский ревматол. журн. 2016;63(1):10-20.
  10. Taniguchi S., Ryu J., Seki M., Sumino T., Tokuhashi Y., Esumi M. Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. J. Orthop. Res. 2012:30:673-78.
  11. Uitterlinden E.J., Jahr H., Koevoet J.L., Jenniskens Y.M., Bierma-Zeinstra S.M., Degroot J., Verhaar J.A., Weinans H., van Osch G.J. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage. 2006;14:250-57.
  12. Альтман Р.Д. Лечение остеоартрита коленного сустава глюкозамином: вопросы фармакокинетики. Клинич. фармакол. 2009; 2(4):359-71.
  13. Chiusaroli R., Piepoli T., Zanelli T., Ballanti P., Lanza M., Rovati L.C., Caselli G. Experimental pharmacology of glucosamine sulfate. Int. J. Rheumatol. 2011;2011:939265.
  14. Алексеева Л.И. Рекомендации по ведению больных остеоартрозом коленных суставов в реальной клинической практике. Лечащий врач. 2015;1:64-9.
  15. Abstracts of the 2010 World Congress on Osteoarthritis. Osteoarthritis and Cartilage 2010;18 (Suppl. 2):1-272.
  16. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V., Hochberg M.C., Wells G. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst. Rev. 2005;CD002946.
  17. Qiu G.X., Gao S.N., Giacovelli G., Rovati L., Setnikar I. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with osteoarthritis. Arzneim Forsch. 1998; 48:469-74.
  18. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., Giacovelli G., Henrotin Y., Dacre J.E., Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet. 2001;357:251-56.
  19. Pavelka K., GatterovaJ.,Olejarova M., Machacek S., Giacovelli G., Rovati L.C. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch. Intern. Med. 2002;162: 2113-23.
  20. Bruyere O., Pavelka K., Rovati L.C., Gatterová J., Giacovelli G., Olejarová M., Deroisy R., Reginster J.Y. Total joint replacement after glucosamine sulphatе treatment in knee ostheoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomized, placebo-controlled trials. Osteoarthritis Cartilage. 2008;16(2):254-60.
  21. Dos Reis R.P., Giacovelli G., Girolami F., André R., Bonazzi A., Rovati L.C. Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials. Open Rheumatol. J. 2011;5:69-77.
  22. Bell B.A., Kantor E.D., Lampe J.W., Shen D.D., White E. Use of glucosamine and chondroitin in relation to mortality. Eur. J. Epidemiol. 2012;27:593603.
  23. Scholtissen S., Bruyere O., Neuprez A., Severens J.L., Herrero-Beaumont G., Rovati L., Hiligsmann M., Reginster J.Y. Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol. Int. J. Clin. Pract. 2010;64:756-62.
  24. Министерство здравоохранения Российской Федерации. Инструкция по медицинскому применению лекарственного препарата Сустагард Артро.
  25. Васильева Л.В., Евстратова Е.Ф., Никитин А.В. Эффективность лечения глюкозамин сульфатом (Сустагард Артро) больных остеоартритом в поликлинических условиях

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies